CR20120185A - Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico - Google Patents

Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico

Info

Publication number
CR20120185A
CR20120185A CR20120185A CR20120185A CR20120185A CR 20120185 A CR20120185 A CR 20120185A CR 20120185 A CR20120185 A CR 20120185A CR 20120185 A CR20120185 A CR 20120185A CR 20120185 A CR20120185 A CR 20120185A
Authority
CR
Costa Rica
Prior art keywords
difluoro
metoxi
amino
nicotinic
bifenil
Prior art date
Application number
CR20120185A
Other languages
English (en)
Inventor
Bernardini Maria Carmen Boix
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of CR20120185A publication Critical patent/CR20120185A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se refiere a un procedimiento para fabricar ácido 2-[(3,5-DIFLUORO-3'-METOXI-1,1'-BIFENIL-4-IL)AMINO]NICOTÍNICOque comprende las etapas de:a) proporcionar 3,5-difluoro-3-metoxibifenil-4-aminab) proporcionar y aislar una sal de aminio de la 3,5-difluoro-3 metoxibifenil-4-amina, yc) además hacer reaccionar la sal de aminio de 3,5-difluoro-3- metoxibifenil-4- amina obtenida en b) para obtener ácido 2-[(3,5-DIFLUORO-3'-METOXI-1,1'-BIFENIL-4-IL)AMINO]NICOTÍNICO
CR20120185A 2009-10-16 2012-04-16 Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico CR20120185A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09382212A EP2314577A1 (en) 2009-10-16 2009-10-16 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid

Publications (1)

Publication Number Publication Date
CR20120185A true CR20120185A (es) 2012-06-11

Family

ID=41402565

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120185A CR20120185A (es) 2009-10-16 2012-04-16 Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico

Country Status (32)

Country Link
US (1) US8598363B2 (es)
EP (2) EP2314577A1 (es)
JP (1) JP5809630B2 (es)
KR (1) KR101699999B1 (es)
CN (2) CN103936668A (es)
AU (1) AU2010306098B2 (es)
BR (1) BR112012008464B1 (es)
CA (1) CA2776328C (es)
CL (1) CL2012000739A1 (es)
CO (1) CO6430508A2 (es)
CR (1) CR20120185A (es)
CY (1) CY1115161T1 (es)
DK (1) DK2488497T3 (es)
EA (1) EA022805B1 (es)
ES (1) ES2467165T3 (es)
HK (1) HK1168101A1 (es)
HR (1) HRP20140523T1 (es)
IL (1) IL218446A (es)
IN (1) IN2012DN01938A (es)
ME (1) ME01812B (es)
MX (1) MX2012004033A (es)
MY (1) MY160308A (es)
NZ (1) NZ598429A (es)
PE (1) PE20121173A1 (es)
PL (1) PL2488497T3 (es)
PT (1) PT2488497E (es)
RS (1) RS53319B (es)
SI (1) SI2488497T1 (es)
SM (1) SMT201400064B (es)
UA (1) UA107811C2 (es)
WO (1) WO2011045059A1 (es)
ZA (1) ZA201201563B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) * 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
JP7343373B2 (ja) * 2019-12-02 2023-09-12 花王株式会社 香料組成物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL182198B1 (en) 1995-06-21 2001-11-30 Asta Medica Ag Pharmaceutic powder holding container with integrated measuring device and powdered
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
GB9804343D0 (en) 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
JP2003504310A (ja) 1999-06-10 2003-02-04 ワーナー−ランバート・カンパニー アミロイドタンパク質凝集阻害方法およびアミロイド沈着物の画像化方法
DE60226855D1 (de) 2001-04-05 2008-07-10 Aventis Pharma Inc Verwendung von (z)-2-cyano-3-hydroxy-but-2-ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose
PE20030120A1 (es) 2001-06-19 2003-02-12 Merck & Co Inc Sal amina de un antagonista de receptor de integrin
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US20050222124A1 (en) * 2002-02-13 2005-10-06 Bromidge Steven M Benzenesulfonamide derivatives as antipsychotic agents
EP1499592A4 (en) * 2002-04-13 2010-01-13 Hanlim Pharmaceutical Co Ltd AMLODIPINE NICOTINATE AND PROCESS FOR PREPARING THE SAME
PE20040844A1 (es) * 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
EP1581478A1 (en) 2002-12-23 2005-10-05 4Sc Ag Dhodh-inhibitors and method for their identification
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SE0400234D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
JP2008500393A (ja) 2004-05-21 2008-01-10 ザ ユーエービー リサーチ ファンデーション ピリミジン合成インヒビターに関する組成物および方法
WO2006022442A1 (ja) 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
AU2005295511A1 (en) 2004-10-19 2006-04-27 Aventis Pharmaceuticals Inc. Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
CN1696100B (zh) * 2005-06-01 2010-11-24 黑龙江福和华星制药集团股份有限公司 痤疮治疗药阿达帕林的新型简捷合成方法
ES2319596B1 (es) * 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
CA2677457A1 (en) 2007-02-06 2008-08-14 Helen Tuvesson Andersson New compounds, methods for their preparation and use thereof
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2210615A1 (en) 2009-01-21 2010-07-28 Almirall, S.A. Combinations comprising methotrexate and DHODH inhibitors
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2230232A1 (en) 2009-03-13 2010-09-22 Almirall, S.A. Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
EP2228367A1 (en) 2009-03-13 2010-09-15 Almirall, S.A. Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors

Also Published As

Publication number Publication date
PL2488497T3 (pl) 2014-07-31
EP2314577A1 (en) 2011-04-27
ZA201201563B (en) 2012-11-28
CA2776328A1 (en) 2011-04-21
IL218446A (en) 2014-08-31
US8598363B2 (en) 2013-12-03
NZ598429A (en) 2014-02-28
EA022805B1 (ru) 2016-03-31
DK2488497T3 (da) 2014-06-10
HK1168101A1 (en) 2012-12-21
EP2488497A1 (en) 2012-08-22
SMT201400064B (it) 2014-07-07
MY160308A (en) 2017-02-28
CY1115161T1 (el) 2016-12-14
HRP20140523T1 (hr) 2014-07-04
WO2011045059A1 (en) 2011-04-21
PT2488497E (pt) 2014-05-28
IL218446A0 (en) 2012-04-30
JP2013507407A (ja) 2013-03-04
BR112012008464B1 (pt) 2021-08-24
CN102574800A (zh) 2012-07-11
MX2012004033A (es) 2012-05-08
AU2010306098A1 (en) 2012-03-15
CN102574800B (zh) 2014-09-17
ES2467165T3 (es) 2014-06-12
CO6430508A2 (es) 2012-04-30
EA201200594A1 (ru) 2012-11-30
AU2010306098B2 (en) 2015-10-15
CA2776328C (en) 2017-08-08
SI2488497T1 (sl) 2014-08-29
BR112012008464A2 (pt) 2015-09-22
EP2488497B1 (en) 2014-03-12
IN2012DN01938A (es) 2015-08-21
KR101699999B1 (ko) 2017-01-26
UA107811C2 (en) 2015-02-25
JP5809630B2 (ja) 2015-11-11
KR20120087131A (ko) 2012-08-06
PE20121173A1 (es) 2012-08-30
US20120245359A1 (en) 2012-09-27
CN103936668A (zh) 2014-07-23
ME01812B (me) 2014-09-20
CL2012000739A1 (es) 2012-10-12
RS53319B (en) 2014-10-31

Similar Documents

Publication Publication Date Title
BRPI0807756A2 (pt) Método para produzir um l-aminoácido.
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
BRPI0916015A2 (pt) "palmilha, método para fabricação de uma palmilha e calçado"
BRPI0816640A2 (pt) "método para produzir produtos de proteína estável ácida e produtos assim produzidos"
BRPI0817212A2 (pt) Pirrolisil-trna sintetase mutante, e método para a produção de proteína tendo aminoácido não-natural integrado nela por sua utilização
EA201100727A1 (ru) Новый способ получения производных аминокислот
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
CR20120185A (es) Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico
BRPI1013346A2 (pt) ferramenta de crimpar, sistema para substituição de válvula cardíaca protética, e , método para colpasar uma válvula cardíaca protética.
BRPI0822775A2 (pt) Método de obtenção de uma proteína heteróloga, purificada, biologicamente ativa.
ECSP10010295A (es) Formulacion de anticuerpo
WO2011057871A3 (de) Verwendung eines zu einem meab-protein homologen proteins zur erhöhung der enzymatischen aktivität einer 3-hydroxycarbonsäure-coa-mutase
WO2009098682A3 (en) Methods and compositions for treatment of mitochondrial disorders
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BRPI1006443A2 (pt) proteína ou peptídeo de fusão de meia-vida aumentada in vivo mantidos por liberação sustentada in vivo, e método para aumentar a meia-vida in vivo usando os mesmos.
CO6690815A2 (es) Métodos y composiciones para inmunoterapia para enfermedad neural
BRPI1013177A2 (pt) construto de ligação de antígeno, polipeptídeo isolado, e, método para tratar doença cardíaca
EP2407472A4 (en) POLYFLUOROALKYLPHOSPHONIC ACID, PROCESS FOR PRODUCING THE SAME, AND REAGENT FOR DEMOWLING IT AS ACTIVE INGREDIENT
WO2012017323A3 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
BRPI0822138A2 (pt) Método para a produção de trifluoreto de titânio, e, sal complexo.
WO2011076946A3 (en) Methods and compositions for the treatment of alzheimer
EP2623655A4 (en) Artificial leather and method for manufacturing same
ECSP12011706A (es) Procedimiento para fabricar ácido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotínico
BR112012002871A2 (pt) método para fabricação de 2,4-dióxotetrahidrofurano-3-carboxilatos
WO2007071649A3 (de) Salze der styphninsäure